 | Up a level |
Mestre, T. A.; Busse, M.; Davis, A. M.; Quinn, L.; Rodrigues, F. B.; Burgunder, Jean-Marc; Carlozzi, N. E.; Walker, F.; Ho, A. K.; Sampaio, C.; Goetz, C. G.; Cubo, E.; Martinez-Martin, P.; Stebbins, G. T. (2018). Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations. Movement disorders clinical practice, 5(4), pp. 361-372. Wiley 10.1002/mdc3.12617
Mestre, T. A.; Carlozzi, N. E.; Ho, A. K.; Burgunder, Jean-Marc; Walker, F.; Davis, A. M.; Busse, M.; Quinn, L.; Rodrigues, F. B.; Sampaio, C.; Goetz, C. G.; Cubo, E.; Martinez-Martin, P.; Stebbins, G. T. (2018). Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life. Movement disorders, 33(5), pp. 742-749. Wiley-Blackwell 10.1002/mds.27317
Cubo, E.; Gonzáles, M.; del Puerto, I.; de Yébenes, J. G.; Arconada, O. F.; Gabriel y Galàn, J. .M; Nirkko, Arto Christian; European Huntington's Disease Initiative Study Group, (2012). Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease. Movement disorders, 2012(27), pp. 439-442. Hoboken, N.J.: Wiley-Blackwell 10.1002/mds.24062
